Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion type Assertion NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_head.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion description "[While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary- and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_provenance.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion evidence source_evidence_literature NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_provenance.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion SIO_000772 25327560 NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_provenance.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion wasDerivedFrom befree-2016 NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_provenance.
- NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_assertion wasGeneratedBy ECO_0000203 NP1230556.RA5e0fYKH1jY896mOdBczPOA9fM8b2qw6jNQ5zQ3nexLs130_provenance.